The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy

Immunotherapy as a treatment for cancer is a growing field of endeavor but reports of success have been limited for epithelial ovarian cancer. Overcoming the challenges to developing more effective therapeutic approaches lies in a better understanding of the factors in cancer cells and the surroundi...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2018-07, Vol.10 (8), p.242
Main Authors: Rodriguez, Galaxia M, Galpin, Kristianne J C, McCloskey, Curtis W, Vanderhyden, Barbara C
Format: Article
Language:English
Subjects:
Adipocytes
Antigen (tumor-associated)
Exosomes
Fibroblasts
Immunotherapy
Lymphocytes B
Lymphocytes T
Natural killer cells
Omentum
Ovarian cancer
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunotherapy as a treatment for cancer is a growing field of endeavor but reports of success have been limited for epithelial ovarian cancer. Overcoming the challenges to developing more effective therapeutic approaches lies in a better understanding of the factors in cancer cells and the surrounding tumor microenvironment that limit response to immunotherapies. This article provides an overview of some ovarian cancer cell features such as tumor-associated antigens, ovarian cancer-derived exosomes, tumor mutational burden and overexpression of immunoinhibitory molecules. Moreover, we describe relevant cell types found in epithelial ovarian tumors including immune cells (T and B lymphocytes, Tregs, NK cells, TAMs, MDSCs) and other components found in the tumor microenvironment including fibroblasts and the adipocytes in the omentum. We focus on how those components may influence responses to standard treatments or immunotherapies.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers10080242